Impact of a transitions of care pilot service established by pharmacy residents within an academic medical center

Medication Therapy Management for Texas MediCAID Patients With Asthma and Chronic Obstructive Pulmonary Disease—A Pilot Study

“…Pharmacist-provided interventions for asthma and COPD patients typically include drug regimen management, education to patients or caregivers of children with asthma, and behavior modification. [24][25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41] Such intervention programs could be focused on a single issue approach (e.g., inhaler technique only), or could follow a comprehensive model that involves complex patient care, such as medication therapy management (MTM). A landmark example of an MTM intervention is The Asheville Project, a U.S. study which included an education and MTM program for patients with asthma.…”

The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review

“…The studies originated from eight different countries: one each from Brazil, 39 Denmark, 63 Ireland, 50 Northern Ireland, 51 and Vietnam 64 ; two studies were from the United Kingdom (UK) 65 , 66 ; three from China 61 , 62 , 67 ; and the remaining 47 were from the United States (US). 24 , 28 , 35 , 36 , 37 , 38 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 , 48 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 68 , 69 , 70 , 71 , 72 , 73 , 74 , 75 , 76 , 77 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 Study sample sizes ranged from 50 to 43,711 (median = 246.5). Study characteristics were tabulated ( Table 1a ) to describe study inclusion criteria, clinical pharmacist activities constituting intervention and the control or comparator group, as well as outcomes or conclusions with statistical results if available ( Table 1b ).…”

“…The 57 studies comprised of 14 RCTs, 39 , 43 , 44 , 51 , 54 , 57 , 61 , 62 , 63 , 64 , 67 , 72 , 74 , 77 and 43 non-randomised studies ( Table 1a ). 24 , 28 , 35 , 36 , 37 , 38 , 40 , 41 , 42 , 45 , 46 , 47 , 48 , 49 , 50 , 52 , 53 , 55 , 56 , 58 , 59 , 60 , 65 , 66 , 68 , 69 , 70 , 71 , 73 , 75 , 76 , 78 , 79 , 80 , 81 , 82 , 83 , 84 , 85 , 86 , 87 , 88 , 89 The non-randomised studies consisted of 11 retrospective pre-post or segmented time-series studies, 38 , 47 , 53 , 59 , 65...…”

“…Study interventions were classified into three clinic types ( Table 1a , Table 1b ): post-discharge clinic pharmacist review only (21/57), 24 , 36 , 43 , 44 , 46 , 50 , 51 , 52 , 53 , 55 , 64 , 66 , 71 , 73 , 74 , 75 , 79 , 80 , 84 , 87 , 89 inpatient clinical pharmacist service with post-discharge clinic pharmacist follow-up (23/57), 38 , 39 , 42 , 45 , 47 , 48 , 49 , 54 , 56 , 57 , 58 , 61 , 62 , 63 , 67 , 70 , 72 , 77 , 78 , 81 , 83 , 86 , 88 and post-discharge collaborative clinic (a clinic pharmacist with other health care professionals) (13/57). 28 , 35 , 37 , 40 , 41 , 59 , 60 , 65 , 68 , 69 , 76...…”

“…Delivery of the clinical pharmacist medication review service varied and included: 29 by phone or predominantly by phone, 38 , 39 , 44 , 45 , 46 , 47 , 50 , 52 , 54 , 55 , 56 , 57 , 58 , 59 , 62 , 63 , 66 , 67 , 69 , 70 , 71 , 72 , 74 , 78 , 79 , 81 , 83 , 84 , 88 18 face-to-face in a clinic setting, 35 , 36 , 37 , 40 , 41 , 43 , 48 , 53 , 60 , 61 , 64 , 65 , 69 , 76 , 80 , 82 , 87 , 89 4 by phone and face-to-face clinic visit, 28 , 42 , 85 , 86 3 face-to-face clinic or by phone, 49 , 75 , 77 2 face-to-face clinic, by phone or virtually, 24 and 1 face-to-face clinic visit and phone. 51 …”